Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine MarketInvestors Business Daily • 01/19/23
Value Crushes Growth to Start 2023: 7 Defensive ‘Strong Buy' Stocks With Big Dividends24/7 Wall Street • 01/19/23
Longevity Biotech Gero Entered a Research Collaboration With Pfizer to Discover Potential Targets for Fibrotic DiseasesBusiness Wire • 01/18/23
Everest Medicines Announces Top-line Data from Phase I Study of EVER206 on Healthy Subjects in ChinaPRNewsWire • 01/17/23
Moderna Comes Swinging For Pfizer, GSK As RSV Vaccine Battle Heats UpInvestors Business Daily • 01/17/23
Pfizer Offers Up Entire Drug And Vaccine Portfolio To World's Poorest Countries At Non-Profit PricesForbes • 01/17/23
Pfizer Stock Dives As Analyst Calls For 'Covid Reset' And Downgrades SharesInvestors Business Daily • 01/17/23
Goldman Sachs Has 6 ‘Hard Landing' Dividend Stocks to Buy Now in Case 2023 Blows Up24/7 Wall Street • 01/17/23
Pfizer expands commitment to ‘An Accord for a Healthier World' to meet unmet medical needs in 45 lower-income countriesMarket Watch • 01/17/23
Pfizer Expands ‘An Accord for a Healthier World' Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income CountriesBusiness Wire • 01/17/23
CDC says it's ‘very unlikely' Pfizer booster carries stroke risk for seniors after launching reviewCNBC • 01/13/23